WJ Elliott, PM Meyer - The Lancet, 2007 - Elsevier Intitial drug therapy used in the trials (and the number of patients with diabetes of the total number
at risk) included: an ARB (1189 of 14 185, or 8·38%), ACE inhibitor (1618 of 22 941, or
7·05%), calcium-channel blocker (CCB, 2791 of 38 607, or 7·23%), placebo (1686 of 24 ... Cited by 300 - Related articles - BL Direct - All 17 versions
- ►nih.gov D Rucker, R Padwal, SK Li, C Curioni, DCW Lau - British Medical Journal, 2007 - bmj.com Page 1. doi:10.1136/bmj.39385.413113.25 published online 15 Nov 2007; BMJ Diana
Rucker, Raj Padwal, Stephanie K Li, Cintia Curioni and David CW Lau overweight:
updated meta-analysis Long term pharmacotherapy for obesity and ... Cited by 163 - Related articles - BL Direct - All 6 versions
- ►nih.gov SR Majumdar, FA McAlister, DT Eurich, RS Padwal, TJ … - British Medical Journal, 2006 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Objectives To determine whether statins reduce ... Cited by 81 - Related articles - BL Direct - All 10 versions
- ►nih.gov DT Eurich, FA McAlister, DF Blackburn, SR Majumdar, … - British Medical Journal, 2007 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Objective To review the literature on the association ... Cited by 50 - Related articles - BL Direct - All 8 versions
EN Liberopoulos, S Tsouli, DP Mikhailidis, MS … - Current Drug …, 2006 - ingentaconnect.com 1Department of Clinical Biochemistry (Vascular Disease Prevention clinics), Royal Free Hospital
University College School of Medicine (University of London), London, UK and 2Department
of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece Cited by 48 - Related articles - BL Direct - All 2 versions
GA Bray, DH Ryan - Gastroenterology, 2007 - Elsevier Three medications with approval for long-term use in the treatment of obesity are currently available
in the United States. Sibutramine (US Food and Drug Administration [FDA] approved in
1997), orlistat (FDA approved in 1999), and rimonabant (available in Europe and given ... Cited by 48 - Related articles - All 20 versions
- ►ahajournals.org DD Schocken, EJ Benjamin, GC Fonarow, HM … - Circulation, 2008 - Am Heart Assoc The increase in heart failure (HF) rates throughout the developed and developing regions of
the world poses enormous challenges for caregivers, researchers, and policymakers.
Therefore, prevention of this global scourge deserves high priority. Identifying and ... Cited by 45 - Related articles - All 8 versions
- ►leeds.ac.uk [PDF] D Mozaffarian, RM Marfisi, G Levantesi, MG Silletta, L … - The Lancet, 2007 - Elsevier We used prospectively obtained data for 8291 Italian patients with a myocardial infarction within
the previous 3 months, who were free of diabetes (determined by medication use, a
physician-reported diagnosis, or fasting glucose ≥7 mmol/L) at baseline. Incidence of ... Cited by 36 - Related articles - All 19 versions
B Richelsen, S Tonstad, S Rössner, S Toubro, L … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—The VLED induced a mean weight loss of 14.4 ± 2..0 kg among the subsequently
randomized patients. The mean weight gain after 3 years was lower with orlistat than with placebo
(4.6 ± 8.6 vs. 7.0 ± 7.1 kg; P < 0.02). The number of participants who achieved ≥5% ... Cited by 37 - Related articles - BL Direct - All 5 versions
